tirzepatide protocol for weight loss made headlines loss. But that's not why longevity doctors are paying attention. As a dual GIP/GLP-1 receptor agonist, it works on pathways that go far beyond metabolism. The data Tirzepatide for maintenance of bodyweight

Tirzepatide involves targeting multiple pathways in the body, resulting in reduced appetite, increased feelings of fullness, and enhanced metabolism

Less serious side effects: Feeling sick (nausea) Diarrhoea Vomiting Abdominal (stomach) pain Feeling less hungry (decreased appetite) General feeling of tiredness Injection site reaction Hypoglycaemia (low blood sugar) when Mounjaro is used with certain medicines for type 2 diabetes mellitus Heartburn Indigestion (dyspepsia) Swelling or bloating of the stomach Constipation Burping or belching Farting (flatulence) Bloating and/or difficulty passing wind Dizziness Dehydration Hair loss Low blood pressure (hypotension) Increased pulse (heart rate) Changes to how foods or drinks taste Changes to sensation or unusual feelings of the skin Serious side effects (call your doctor straight away or go straight to the emergency department of your nearest hospital): Acute pancreatitis Severe pain in the stomach or back that does not go away and vomiting and/or diarrhoea

BCBS of Alabama does not cover Mounjaro for weight loss under any line of business

Commonly prescribed GLP-1 receptor agonists in the UK include: Semaglutide (Ozempic, Wegovy, Rybelsus [oral formulation]) Dulaglutide (Trulicity) Liraglutide (Victoza, Saxenda) Exenatide (Byetta [twice-daily], Bydureon [weekly]) Tirzepatide (Mounjaro) - a dual GIP/GLP-1 receptor agonist with similar considerations [6] [7] These medications are typically administered via subcutaneous injection (daily, twice-daily or weekly depending on the specific formulation), with semaglutide also available as an oral tablet